27941991|t|In vivo Distribution and Clearance of Purified Capsular Polysaccharide from Burkholderia pseudomallei in a Murine Model
27941991|a|Burkholderia pseudomallei is the causative agent of melioidosis, a severe infection prominent in northern Australia and Southeast Asia. The " gold standard " for melioidosis diagnosis is bacterial isolation, which takes several days to complete. The resulting delay in diagnosis leads to delayed treatments, which could result in death. In an attempt to develop better methods for early diagnosis of melioidosis, B. pseudomallei capsular polysaccharide (CPS) was identified as an important diagnostic biomarker. A rapid lateral flow immunoassay utilizing CPS - specific monoclonal antibody was developed and tested in endemic regions worldwide. However, the in vivo fate and clearance of CPS has never been thoroughly investigated. Here, we injected mice with purified CPS intravenously and determined CPS concentrations in serum, urine, and major organs at various intervals. The results indicate that CPS is predominantly eliminated through urine and no CPS accumulation occurs in the major organs. Immunoblot analysis demonstrated that intact CPS was excreted through urine. To understand how a large molecule like CPS was eliminated without degradation, a 3-dimenational structure of CPS was modeled. The predicted CPS structure has a rod-like shape with a small diameter that could allow it to flow through the glomerulus of the kidney. CPS clearance was determined using exponential decay models and the corrected Akaike Information Criterion. The results show that CPS has a relatively short serum half-life of 2.9 to 4.4 hours. Therefore, the presence of CPS in the serum and/or urine suggests active melioidosis infection and provides a marker to monitor treatment of melioidosis.
27941991	0	7	In vivo	T082	C1515655
27941991	8	20	Distribution	T169	C1704711
27941991	25	34	Clearance	T080	C0449297
27941991	38	70	Purified Capsular Polysaccharide	T109,T121	C0982056
27941991	76	101	Burkholderia pseudomallei	T007	C0033819
27941991	107	119	Murine Model	T050	C0012644
27941991	120	145	Burkholderia pseudomallei	T007	C0033819
27941991	153	168	causative agent	T033	C0449411
27941991	172	183	melioidosis	T047	C0025229
27941991	187	193	severe	T080	C0205082
27941991	194	203	infection	T046	C3714514
27941991	204	213	prominent	T080	C0205402
27941991	217	235	northern Australia	UnknownType	C0682376
27941991	240	254	Southeast Asia	T083	C0003983
27941991	262	275	gold standard	T080	C0150110
27941991	282	293	melioidosis	T047	C0025229
27941991	294	303	diagnosis	T060	C0430022
27941991	307	326	bacterial isolation	T059	C0430402
27941991	340	352	several days	T033	C3845714
27941991	356	364	complete	T080	C0205197
27941991	370	379	resulting	T169	C0332294
27941991	380	385	delay	T079	C0205421
27941991	389	398	diagnosis	T060	C0430022
27941991	408	426	delayed treatments	T033	C3693346
27941991	440	446	result	T169	C1274040
27941991	450	455	death	T033	C1306577
27941991	463	470	attempt	T051	C1516084
27941991	482	488	better	T080	C0332272
27941991	489	496	methods	T060	C0430022
27941991	501	516	early diagnosis	T060	C0596473
27941991	520	531	melioidosis	T047	C0025229
27941991	533	548	B. pseudomallei	T007	C0033819
27941991	549	572	capsular polysaccharide	T109,T121	C0982056
27941991	574	577	CPS	T109,T121	C0982056
27941991	583	593	identified	T080	C0205396
27941991	600	609	important	T080	C3898777
27941991	610	620	diagnostic	T169	C0348026
27941991	621	630	biomarker	T201	C0005516
27941991	653	664	immunoassay	T059	C0020980
27941991	665	674	utilizing	T169	C1524063
27941991	675	678	CPS	T109,T121	C0982056
27941991	681	689	specific	T080	C0205369
27941991	690	709	monoclonal antibody	T116,T129	C0003250
27941991	728	734	tested	T169	C0039593
27941991	738	753	endemic regions	T083	C0017446
27941991	754	763	worldwide	T082	C0332464
27941991	778	785	in vivo	T082	C1515655
27941991	795	804	clearance	T080	C0449297
27941991	808	811	CPS	T109,T121	C0982056
27941991	816	821	never	T079	C2003901
27941991	838	850	investigated	T169	C1292732
27941991	861	874	injected mice	T015	C0025929
27941991	880	892	purified CPS	T109,T121	C0982056
27941991	893	906	intravenously	T082	C0348016
27941991	911	921	determined	T080	C0521095
27941991	922	925	CPS	T109,T121	C0982056
27941991	926	940	concentrations	T081	C0439265
27941991	944	949	serum	T031	C0229671
27941991	951	956	urine	T031	C0042036
27941991	962	967	major	T080	C0205164
27941991	968	974	organs	T023	C0178784
27941991	978	985	various	T081	C0439064
27941991	986	995	intervals	T079	C1272706
27941991	1001	1008	results	T169	C1274040
27941991	1009	1017	indicate	T078	C0392360
27941991	1023	1026	CPS	T109,T121	C0982056
27941991	1044	1054	eliminated	T080	C0849355
27941991	1055	1062	through	T169	C0332273
27941991	1063	1068	urine	T031	C0042036
27941991	1073	1075	no	T033	C0205160
27941991	1076	1079	CPS	T109,T121	C0982056
27941991	1080	1092	accumulation	T033	C4055506
27941991	1093	1099	occurs	T079	C2745955
27941991	1107	1112	major	T080	C0205164
27941991	1113	1119	organs	T023	C0178784
27941991	1121	1140	Immunoblot analysis	T059	C0020985
27941991	1159	1165	intact	T080	C0205266
27941991	1166	1169	CPS	T109,T121	C0982056
27941991	1174	1182	excreted	T039	C0221102
27941991	1183	1190	through	T169	C0332273
27941991	1191	1196	urine	T031	C0042036
27941991	1201	1211	understand	T041	C0162340
27941991	1218	1223	large	T081	C0549177
27941991	1224	1232	molecule	T167	C0567416
27941991	1238	1241	CPS	T109,T121	C0982056
27941991	1246	1256	eliminated	T080	C0849355
27941991	1257	1264	without	T080	C0332288
27941991	1265	1276	degradation	T044	C0314674
27941991	1280	1304	3-dimenational structure	T082	C0026377
27941991	1308	1311	CPS	T109,T121	C0982056
27941991	1329	1338	predicted	T078	C0681842
27941991	1339	1342	CPS	T109,T121	C0982056
27941991	1343	1352	structure	T082	C0678594
27941991	1359	1373	rod-like shape	T082	C0332479
27941991	1387	1395	diameter	T081	C1301886
27941991	1424	1431	through	T169	C0332273
27941991	1436	1460	glomerulus of the kidney	T023	C0022663
27941991	1462	1465	CPS	T109,T121	C0982056
27941991	1466	1475	clearance	T080	C0449297
27941991	1480	1490	determined	T080	C0521095
27941991	1497	1521	exponential decay models	T060	C0430022
27941991	1540	1568	Akaike Information Criterion	T080	C0205556
27941991	1574	1581	results	T169	C1274040
27941991	1592	1595	CPS	T109,T121	C0982056
27941991	1613	1618	short	T081	C2350002
27941991	1619	1624	serum	T031	C0229671
27941991	1625	1634	half-life	T079	C0018517
27941991	1671	1679	presence	T033	C0150312
27941991	1683	1686	CPS	T109,T121	C0982056
27941991	1694	1699	serum	T031	C0229671
27941991	1707	1712	urine	T031	C0042036
27941991	1713	1721	suggests	T078	C1705535
27941991	1729	1750	melioidosis infection	T047	C0025229
27941991	1766	1772	marker	T201	C0005516
27941991	1776	1793	monitor treatment	T058	C0150369
27941991	1797	1808	melioidosis	T047	C0025229